| 000 | 01662 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517142203.0 | ||
| 264 | 0 | _c20180116 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2016.12.027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPradere, P | |
| 245 | 0 | 0 |
_aAllergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c04 2017 |
||
| 300 |
_a308-309 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAspergillosis, Allergic Bronchopulmonary _xchemically induced |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 | _aSunitinib |
| 700 | 1 | _aMichot, J M | |
| 700 | 1 | _aChampiat, S | |
| 700 | 1 | _aDanlos, F X | |
| 700 | 1 | _aMarabelle, A | |
| 700 | 1 | _aLambotte, O | |
| 700 | 1 | _aAlbiges, L | |
| 700 | 1 | _aLe Pavec, J | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 75 _gp. 308-309 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2016.12.027 _zAvailable from publisher's website |
| 999 |
_c26934822 _d26934822 |
||